Media-OutReach Newswire Poredeen Appoints ICB as Exclusive Named Patient Program Manager for HMTM# in Hong Kong and Macau
Media-OutReach Newswire A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore
Media-OutReach Newswire G-NiiB Oral Microbiome Immunity Formula SIM01 Alleviates Post-COVID-19 Conditions
Media-OutReach Newswire G-NiiB Oral Microbiome Immunity Formula SIM01 Alleviates Post-COVID-19 Conditions
Media-OutReach Newswire HKBU-led research discovers therapeutic potential of hyodeoxycholic acid for non-alcoholic fatty liver disease
Media-OutReach Newswire Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness
Media-OutReach Newswire New antibiotic drug developed by HKU Chemistry research team approved for clinical trials in humans
Media-OutReach Newswire M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials
Media-OutReach Newswire SSY announces 2023 interim results Net profit HK$639 million; Interim dividend HK$0.07/share Determined to seize opportunities; Maintain stable & healthy development
Media-OutReach Newswire Southern Star Research Adopts Veeva Vault eTMF and Veeva Vault CTMS to Streamline Trial Processes
Media-OutReach Newswire Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA
Media-OutReach Newswire Novel Chinese medicine for constipation developed by HKBU authorised by U.S. FDA for clinical trial
Media-OutReach Newswire US radiologists working with Nutex Health Hospitals now have access to world-class DrAid™, an artificial intelligence doctor’s assistant
Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection
Media-OutReach Newswire LiveSpo represents Vietnam, announces world's first spore probiotics in nasal spray form at the BIO International Convention
Media-OutReach Newswire LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China